Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial.

@article{Zhang2014NinemonthAA,
  title={Nine-month angiographic and two-year clinical follow-up of polymer-free sirolimus-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease: the Nano randomized trial.},
  author={Yaojun Zhang and Fang Chen and Takashi Muramatsu and Bo Xu and Zhanquan Li and Junbo Ge and Qiyuan He and Zhijian Yang and Shumei Li and Lefeng Wang and Haichang Wang and Ben He and Kang Li and Guoxian Qi and Tianchang Li and Hesong Zeng and Jianjun Peng and Tieming Jiang and Qiutang Zeng and Jianhua Zhu and Guosheng Fu and Christos V. Bourantas and Patrick W Serruys and Yong Huo},
  journal={Chinese medical journal},
  year={2014},
  volume={127 11},
  pages={
          2153-8
        }
}
BACKGROUND First generation drug-eluting stents (DES) were associated with a high incidence of late stent thrombosis (ST), mainly due to delayed healing and re-endothelization by the durable polymer coating. This study sought to assess the safety and efficacy of the Nano polymer-free sirolimus-eluting stent (SES) in the treatment of patients with de novo coronary artery lesions. METHODS The Nano trial is the first randomized trial designed to compare the safety and efficacy of the Nano… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-7 OF 7 CITATIONS

Similar Papers

Loading similar papers…